We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PMCB market cap is 18.52M. The company's latest EPS is USD -0.5009 and P/E is -4.25.
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.32M | -1.55M | -902k | -2.08M | -1.41M |
| Net Income | -1.88M | -764k | -126k | -3.5M | -5.53M |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.1M | -3.83M | -3.62M | -4.39M | -6.46M |
| Net Income | -4.07M | -3.83M | -3.55M | -4.24M | -4.32M |
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 82.35M | 77.95M | 73.28M | 79.88M | 78.88M |
| Total Liabilities | 1.31M | 828k | 587k | 20.4M | 20.81M |
| Total Equity | 81.04M | 77.12M | 72.69M | 42.73M | 36.77M |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.78M | 6.17M | 7.4M | 90.62M | 73.28M |
| Total Liabilities | 742k | 1.08M | 725k | 704k | 587k |
| Total Equity | 5.04M | 5.09M | 6.68M | 89.92M | 72.69M |
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.96M | -3.51M | -3.79M | 344k | -1.64M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -5.48M | -9.25M | -13.56M | 6.28M | 7.03M |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.88M | -2.34M | -3.33M | -4.12M | -3.79M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 2.34M | 2.73M | 4.64M | 87.31M | -13.56M |
| Market Cap | 18.52M |
| Price to Earnings Ratio | -4.25 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.27 |
| Price to Book Ratio | 0.25 |
| Dividend Yield | - |
| Shares Outstanding | 8.62M |
| Average Volume (1 week) | 7.85k |
| Average Volume (1 Month) | 13.27k |
| 52 Week Change | -26.12% |
| 52 Week High | 3.23 |
| 52 Week Low | 1.92 |
| Spread (Intraday) | 0.21 (9.13%) |
| Company Name | PharmaCyte Biotech Inc |
| Address |
401 ryland st ste 200-a reno, nevada 89502 |
| Website | https://ir.pharmacyte.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
